Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 36,31 | 76,26 | 2024-03-26 |
| Avanza Pension | 5,56 | 1,84 | 2024-03-26 |
| Nordnet Pensionsförsäkring | 4,75 | 1,51 | 2024-03-26 |
| Rolf Karlsson | 3,90 | 1,24 | 2024-03-26 |
| Hans Nygren | 1,93 | 0,61 | 2024-03-26 |
| Gramsh Gashi | 1,10 | 0,35 | 2024-03-26 |
| Creative Invest One AB | 0,77 | 0,25 | 2024-03-26 |
| Swedbank Försäkring | 0,76 | 0,24 | 2024-03-26 |
| Försäkringsaktiebolaget Skandia | 0,75 | 0,24 | 2024-03-26 |
| Creative Networks X AB | 0,53 | 0,17 | 2024-03-26 |
2024-05-25 Delårsrapport 2024-Q3
2024-08-28 Bokslutskommuniké 2024
2024-11-21 Årsstämma 2024
2024-11-21 Delårsrapport 2025-Q1
